Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT05802459
Recruiting Observational

Evaluation of the Functional Status of Jejunoplasty and Coloplasty and Its Impact on Quality of Life (CEREC)

NCT05802459 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2022-12-15
Last updated
2023-04-06

Condition(s) studied

Quality of LifeDysphagia

Investigational drug(s) / intervention(s)

EORTC QLQ-C30EORTC QLQ-OG25GIQLISWAL QoLVideofluoroscopy

EORTC QLQ-C30: central generic questionnaire associated with different disease specific modules

EORTC QLQ-OG25: module to assess the quality of life in patients with esophagogastric disease.

GIQLI: Gastrointestinal Quality of Life Index. It is a gastrointestinal quality of life scale.

SWAL QoL: Swallowing Quality of Life questionnaire. This is a quality of life and quality of attention questionnaire for patients with oropharyngeal dysphagia.

Videofluoroscopy: It consists of 14 items that represent the oral and pharyngeal function observed in the VDF. It allows to quantify the severity of dysphagia.

Study summary

The goal of this prospective population-based cohort study is to assess:

* The evolution of the functional status of patients undergoing complex esophageal reconstruction
* Its impact on quality of life, depending on the type of conduit performed.

Participants

* Will be asked to complete different quality of life questionnaires during every follow-up visit
* Will undergo additional tests to assess functionality

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients (≥ 18 years of age) and of both gender. * Candidates for complete esophageal reconstruction with cervical anastomosis, regardless of the etiology of the esophagectomy. * Decision to indicate a coloplasty (+/- supercharged) or jejunoplasty (free, pedunculated +/- supercharged) as surgical technique after evaluation by the UREC Committee. * Acceptance to participate in the study and comply with the program of procedures (schedule of visits). * Signing of the informed consent. Exclusion Criteria: * Patients who withdraw their informed consent at any time during the course of the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Uversitari de Bellvitge Barcelona Spain Recruiting

More Hospital Universitari de Bellvitge trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05802459 on ClinicalTrials.gov ↗ ← All trials in Spain